UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of April 2020

 

Commission File Number 000-56026

 

TODOS MEDICAL LTD.

(Translation of registrant’s name into English)

 

1 Hamada Street

Rehovot, Israel 7670301

Tel: (011) (972) 8-633-3964

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

[X] Form 20-F   [  ] Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 

 

 

 

 

 

Extraordinary General Meeting

 

The Company hereby furnishes the following documents:

 

(a) Notice and Proxy Statement with respect to the Company’s Extraordinary General Meeting of Shareholders to be held on May 11, 2020. The Proxy Statement describes the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy, and various other details related to the meeting; and

 

(b) A Proxy Card whereby holders of the Company’s shares may vote at the meeting without attending in person.

 

Financial Statements and Exhibits.

 

The following Exhibits are filed as part of this Report.

 

Exhibit

Number

  Description
     
99.1  

Notice and Proxy Statement for the Extraordinary General Meeting of Shareholders of the Company to be held on May 11, 2020

     
99.2   Proxy Card for the Extraordinary General Meeting of Shareholders of the Company to be held on May 11, 2020

 

-2-

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  TODOS MEDICAL LTD.
   
  By: /s/ Gerald Commissiong
  Name: Gerald Commissiong
  Title: Chief Executive Officer
     
Date: April 14, 2020    

 

-3-